Axon Enterprise, Inc. (NASDAQ:AXON) Given Average Rating of “Buy” by Analysts

Axon Enterprise, Inc. (NASDAQ:AXON) has been given an average recommendation of “Buy” by the thirteen analysts that are presently covering the firm, MarketBeat Ratings reports. Thirteen investment analysts have rated the stock with a buy rating. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $488.67.

AXON has been the topic of several recent research reports. The Goldman Sachs Group boosted their price objective on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Northland Securities boosted their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their target price for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Needham & Company LLC boosted their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Finally, Robert W. Baird boosted their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th.

Insider Activity

In other news, President Joshua Isner sold 20,000 shares of the business’s stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the completion of the sale, the president now owns 208,166 shares in the company, valued at approximately $126,179,820.90. The trade was a 8.77 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Jeffrey C. Kunins sold 1,035 shares of the business’s stock in a transaction dated Monday, December 23rd. The stock was sold at an average price of $624.47, for a total value of $646,326.45. Following the sale, the insider now owns 124,243 shares of the company’s stock, valued at $77,586,026.21. The trade was a 0.83 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 55,862 shares of company stock valued at $32,814,021 in the last 90 days. 6.10% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Axon Enterprise

Institutional investors and hedge funds have recently made changes to their positions in the business. Quent Capital LLC raised its position in shares of Axon Enterprise by 1,875.0% during the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after acquiring an additional 75 shares in the last quarter. Prestige Wealth Management Group LLC increased its position in Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after buying an additional 44 shares during the period. Brooklyn Investment Group acquired a new stake in Axon Enterprise in the third quarter worth $41,000. Planning Capital Management Corp increased its position in Axon Enterprise by 83.3% in the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after buying an additional 55 shares during the period. Finally, Friedenthal Financial acquired a new stake in Axon Enterprise in the third quarter worth $51,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Axon Enterprise Price Performance

Axon Enterprise stock opened at $604.32 on Tuesday. Axon Enterprise has a 52 week low of $241.72 and a 52 week high of $698.67. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The firm’s 50-day simple moving average is $578.35 and its 200 day simple moving average is $430.50. The firm has a market capitalization of $46.08 billion, a PE ratio of 156.16, a P/E/G ratio of 14.19 and a beta of 1.01.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.